Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 5, 2013, Pages

  Ahmed, Rashed M ^a,b,c,d   Mohamed, El Haddad A ^a,b,c,d   Ashraf, Mostafa ^a,b,c,d   Maithili, Shenoy ^a,b,c,d   Nabil, Farag ^a,b,c,d   Rami, Raymond ^a,b,c,d   Mohamed, Tahir I ^a,b,c,d  

^a Dar Al Fouad Hospital   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

percutaneous coronary intervention; remote ischemic preconditioning; troponin

Indexed keywords

C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TROPONIN T;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ATTENUATION; BLOOD PRESSURE CUFF; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIC PRECONDITIONING; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION;

PERCUTANEOUS CORONARY INTERVENTION; REMOTE ISCHEMIC PRECONDITIONING; TROPONIN;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATINE KINASE, MB FORM; EGYPT; FEMALE; HUMANS; INFLAMMATION MEDIATORS; ISCHEMIC PRECONDITIONING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T; UPPER EXTREMITY;

EID: 84886950781     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24825     Document Type: Article

References (48)

1. Porto I, Blackman DJ, Nicolson D, Niccoli G, Kahn FZ, et al. What is the incidence of myocardial necrosis in elective patients discharged on the same day following percutaneous coronary intervention? Heart. 2004; 90: 1489-1490.
2. Nageh T, Sherwood RA, Harris BM, et al. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol 2003; 92: 285-293.
3. Nageh T, Sherwood RA, Harris BM, Thomas MR,. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Heart. 2005; 91: 1181-1185.
4. Ramirez-Moreno A, Cardenal R, Pera C, Pagola C, Guzman M, et al. Predictors and prognostic value of myocardial injury following stent implantation. Int J Cardiol 2004; 97: 193-198.
5. Kizer JR, Muttrej MR, Matthai WH, McConnell J, Nardone H, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003; 24: 1314-1322.
6. Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003; 145: 522-528.
7. Cantor WJ, Newby LK, Christenson RH, Tuttle RH, Hasselblad V, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1738-1744.
8. Blankenship JC, Islam MA, Wood GC, Iliadis EA,. Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation. Catheter Cardiovasc Interv 2004; 63: 31-41.
9. Prasad A, Herrmann J,. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011; 364: 453-464.
10. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005; 111: 1027-1032.
11. Porto I, Selvanayagam JB, Van Gaal WJ, Prati F, Cheng A, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006; 114: 662-669.
12. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P,. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893-899.
13. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: A randomised controlled trial. Lancet. 2007; 370: 5759.
14. Gunaydin B, Cakici I, Soncul H, Kalaycioglu S, Cevik C, et al. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res 2000; 41: 493-496.
15. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: First clinical application in humans. J Am Coll Cardiol 2006; 47: 2277-2282.
16. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: A randomized controlled trial. Circulation 2007; 116 (11 Suppl): I98-I105.
17. Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, Kolocassides KG, Adamopoulos S, et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning? Heart 2006; 92: 1821-1826.
18. Zhou K, Yang B, Zhou XM, Tan CM, Zhao Y, et al. Effects of remote ischemic preconditioning on the flow pattern of the left anterior descending coronary artery in normal subjects. Int J Cardiol 2007; 122: 250-251.
19. Stephen P,., Hoole, Patrick M,., Heck, Paul A,., White, et al. Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary intervention. Angiology 2009: 60: 403-411.
20. Stephen P,., Hoole, Patrick M,., Heck, Linda Sharples, et al. Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study. Circulation 2009; 119; 820-827.
21. Schiano P, Gabriel Steg P,. Measurement and prevention of myocardial injury during percutaneous coronary intervention. Heart 2007; 93: 656-657.
22. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG,. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528-1536.
23. Brener SJ, Ellis SG, Schneider J, Topol EJ,. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 2002; 23: 869-876.
24. Nallamothu BK, Bates ER,. Periprocedural myocardial infarction and mortality: Causality versus association. J Am Coll Cardiol 2003; 42: 1412-1414.
25. Bahrmann P, Figulla HR, Wagner M, Ferrari M, Voss A, Werner GS,. Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions. Heart. 2005; 91: 1186-1192.
26. Thygesen K, Alpert JS, White HD,. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50: 2173-2195.
27. Murry CE, Jennings RB, Reimer KA,. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
28. Birnbaum Y, Hale SL, Kloner RA,. Ischemic preconditioning at a distance: Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997; 96: 1641-1646.
29. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002; 106: 2881-2883.
30. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD,. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996; 94: 2193-2200.
31. Pell TJ, Baxter GF, Yellon DM, Drew GM,. Renal ischemia preconditions myocardium: Role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol 1998; 275: H1542-H1547.
32. Schoemaker RG, van Heijningen CL,. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000; 278: H1571-H1576.
33. Tang ZL, Dai W, Li YJ, Deng HW,. Involvement of capsaicin-sensitive sensory nerves in early and delayed cardioprotection induced by a brief ischaemia of the small intestine. Naunyn Schmiedebergs Arch Pharmacol 1999; 359: 243-247.
34. Dickson EW, Reinhardt CP, Renzi FP, Becker RC, Porcaro WA, Heard SO,. Ischemic preconditioning may be transferable via whole blood transfusion: Preliminary evidence. J Thromb Thrombolysis 1999; 8: 123-129.
35. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, et al. Rabbit heart can be 'preconditioned' via transfer of coronary effluent. Am J Physiol 1999; 277: H2451-H2457.
36. Dickson EW, Porcaro WA, Fenton RA, Heard SO, Reindhardt CP, et al. 'Preconditioning at a distance' in the isolated rabbit heart. Acad Emerg Med 2000; 7: 311-317.
37. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genom 2004; 19: 143-150.
38. Konstantinov IE, Li J, Cheung MM, Shimizu M, Stokoe J, et al. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation 2005; 79: 1691-1695.
39. Kristiansen SB, Henning O, Kharbanda RK, Nielsen-Kudsk JE, Schmidt MR, et al. Remote preconditioning reduces ischemic injury in the explanted heart by a KATP channel-dependent mechanism. Am J Physiol Heart Circ Physiol 2005; 288: H1252-H1256.
40. Serejo FC, Rodrigues LF Jr, Silva Tavares KC, de Carvalho AC, Nascimento JH,. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J Cardiovasc Pharmacol 2007; 49: 214-220.
41. Kant R, Diwan V, Jaggi AS, Singh N, Singh D,. Remote renal preconditioning-induced cardioprotection: A key role of hypoxia inducible factor-prolyl 4-hydroxylases. Mol Cell Biochem 2008; 312: 25-31.
42. Peralta C, Fernandez L, Panes J, Prats N, Sans M, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-113.
43. Vinten-Johansen J,. Postconditioning: A mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev 2007; 12: 235-244.
44. Hausenloy DJ, Yellon DM,. Preconditioning and postconditioning: United at reperfusion. Pharmacol Ther 2007; 116: 173-191.
45. Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, et al. Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation 2007; 116: 1386-1395.
46. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genom 2004; 19: 143-150.
47. Hassouna A, Loubani M, Matata BM, Fowler A, Standen NB, et al. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res. 2006; 69: 450-458.
48. Miller WL, Garratt KN, Burritt MF, Reeder GS, Jaffe AS,. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest 2004; 125: 275-280.